Biocompatible melanin based theranostic agent for in vivo detection and ablation of orthotopic micro-hepatocellular carcinoma
Source abstract
Abstract
Early diagnosis and therapy of hepatocellular carcinoma (HCC) is critical to improve the five-year survival rates of patients. Theranostic agents synergized with photothermal ablation are expected to realize the early detection and treatment of orthotopic HCC. However, conventional metallic nanoagents are limited by their potential bio-toxicity to surrounding normal organs. Recently, endogenous biological melanin pigments have been utilized to develop nanoplatforms due to their excellent biocompatibility and degradability. Whereas, the insufficient capability of PEGylated melanin nanoparticles (PEG-MNPs) in photoacoustic (PA) imaging limits their further biomedical applications. Paradoxically, it is difficult to meet these two different requirements. Herein, a multifunctional nanoagent based on melanin (MNPs) conjugating the near-infrared (NIR) dye IR820 was successfully designed and fabricated. Encapsulation by polyethylene glycol (PEG) renders the solubility in water and allows the physical absorption of IR820 for enhanced photoacoustic (PA) performance and photothermal therapy. Besides, PEG coating on the surface of IR820-PEG-MNPs resulted in a reduction in swallowing in the reticuloendothelial system of the liver and spleen, prolonging the circulation time in the blood and increasing the accumulation in the tumor. The IR820-PEG-MNPs displayed satisfactory PA and T1-weighted magnetic resonance imaging (MRI) signals in aqueous solution as well as strong photothermal efficiency. Compared with prior injection, PA/MR signals of the tumor region were enhanced by 4.13- and 1.60-fold, respectively, which could effectively detect lesions smaller than ∼1.8 mm. Furthermore, the high photothermal conversion efficiency (40.2%) endowed the IR820-PEG-MNPs with the capability of selectively ablating tumors in orthotopic HCC mouse models under the guidance of PA/MR imaging. This work broadens the biomedical applications of melanin-based agent, which are promising for the precise diagnosis of orthotopic micro HCC and imaging guided photothermal ablation.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photoacoustic and Ultrasonic Imaging · Hepatocellular Carcinoma Treatment and Prognosis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Hepatobiliary Surgery
Zhujiang Hospital
Southern Medical University
Guangzhou
PR China
Center for Molecular Imaging and Translational Medicine
School of Public Health
Xiamen University
Xiamen
Funding
National Basic Research Program of China · National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities · Natural Science Foundation of Fujian Province
References (46)
Show source-provided references
1. International Agency for Research on Cancer , Cancer today , World Health Organization , 2018 ( https://gco.iarc.fr/today/home )
2. Bray · CA Cancer J. Clin. · 2018 · 68 · 39410.3322/caac.21492 ↗
3. Bruix · Gastroenterology · 2016 · 150 · 83510.1053/j.gastro.2015.12.041 ↗
4. Vitale · J. Hepatol. · 2017 · 66 · 41210.1016/j.jhep.2016.09.012 ↗
5. Wang · Science · 2012 · 335 · 145810.1126/science.1216210 ↗
6. Zheng · J. Biophotonics · 2018 · 11 · e20180007310.1002/jbio.201800073 ↗
7. Maturi · Biomater. Sci. · 2019 · 7 · 174610.1039/C8BM01444B ↗
8. Chen · Biomaterials · 2016 · 106 · 14410.1016/j.biomaterials.2016.08.022 ↗
9. European Association for the Study of the Liver · J. Hepatol. · 2018 · 69 · 18210.1016/j.jhep.2018.03.019 ↗
10. Marrero · Hepatology · 2018 · 68 · 72310.1002/hep.29913 ↗
11. Villanueva · N. Engl. J. Med. · 2019 · 380 · 145010.1056/NEJMra1713263 ↗
12. Parchur · ACS Nano · 2018 · 12 · 659710.1021/acsnano.8b01424 ↗
13. Liu · Chem. Soc. Rev. · 2019 · 48 · 205310.1039/C8CS00618K ↗
14. Fernandes · Biomater. Sci. · 2020 · 8 · 299010.1039/D0BM00222D ↗
15. Wang · Nanoscale · 2019 · 11 · 1532610.1039/C9NR05236D ↗
16. Han · ACS Nano · 2019 · 13 · 437910.1021/acsnano.8b09607 ↗
17. Liu · Chem. Soc. Rev. · 2019 · 48 · 205310.1039/C8CS00618K ↗
18. Liu · Adv. Mater. · 2017 · 29 · 1606129.1
19. Rabiee · Biomaterials · 2019 · 232 · 11970710.1016/j.biomaterials.2019.119707 ↗
20. Yu · Nat. Commun. · 2018 · 9 · 76610.1038/s41467-018-03119-w ↗
21. Maher · Environ. Sci. Pollut. Res. Int. · 2020 · 27 · 1911510.1007/s11356-019-05111-3 ↗
22. Liopo · Photoacoustics · 2015 · 3 · 3510.1016/j.pacs.2015.02.001 ↗
23. Caldas · Acta Biomater. · 2020 · 105 · 2610.1016/j.actbio.2020.01.044 ↗
24. Enochs · Radiology · 1997 · 204 · 41710.1148/radiology.204.2.9240529 ↗
25. Wang · J. Mater. Chem. B · 2019 · 7 · 13310.1039/C8TB02724B ↗
26. Zhang · Theranostics · 2018 · 8 · 159110.7150/thno.22430 ↗
27. Fan · J. Am. Chem. Soc. · 2014 · 136 · 1518510.1021/ja505412p ↗
28. Jiang · Biomaterials · 2019 · 192 · 29210.1016/j.biomaterials.2018.11.021 ↗
29. Xu · Biomater. Sci. · 2017 · 6 · 20710.1039/C7BM00635G ↗
30. Wang · Biomater. Sci. · 2019 · 7 · 406010.1039/C9BM01052A ↗
31. Chen · Biomater. Sci. · 2020 · 8 · 37910.1039/C9BM01580A ↗
32. Yang · ACS Appl. Mater. Interfaces · 2019 · 11 · 4267110.1021/acsami.9b16861 ↗
33. Fang · EBioMedicine · 2019 · 41 · 69310.1016/j.ebiom.2019.02.017 ↗
34. Wang · Theranostics · 2018 · 8 · 122710.7150/thno.22872 ↗
35. Fernandez-Fernandez · Mol. Imaging · 2012 · 11 · 9910.2310/7290.2011.00031 ↗
36. Hu · Small · 2018 · 14 · e180299410.1002/smll.201802994 ↗
37. Zhang · Adv. Mater. · 2015 · 27 · 506310.1002/adma.201502201 ↗
38. She · Biomaterials · 2013 · 34 · 161310.1016/j.biomaterials.2012.11.007 ↗
39. Ulbrich · Chem. Rev. · 2016 · 116 · 533810.1021/acs.chemrev.5b00589 ↗
40. Van Opdenbosch · Immunity · 2019 · 50 · 135210.1016/j.immuni.2019.05.020 ↗
41. Steinberg · Photoacoustics · 2019 · 14 · 7710.1016/j.pacs.2019.05.001 ↗
42. Huang · Biomater. Sci. · 2019 · 7 · 47210.1039/C8BM00642C ↗
43. Sun · Nanoscale · 2018 · 10 · 1058410.1039/C8NR01215F ↗
44. Hirasawa · Appl. Opt. · 2018 · 57 · 238310.1364/AO.57.002383 ↗
45. Lu · ACS Appl. Mater. Interfaces · 2016 · 8 · 1437910.1021/acsami.6b03059 ↗
46. Ishizawa · Cancer · 2009 · 115 · 249110.1002/cncr.24291 ↗